在阿司匹林和纤溶治疗基础上加用氯吡格雷治疗St段抬高心肌梗死
Addition of Ckopidogrek to Aspirin and Fibrinokytic Therapy for Myocardiak Infarction with ST-Segment Ekevation
Marc S. Sabatine M.D. M.P.H. 等
美国波士顿哈佛医学院Brigham和妇女医院内科心血管科TIMI研究小组，等
结论 在年龄≤75岁、患有ST段抬高心肌梗死并接受阿司匹林和标准纤溶方案治疗的病人中，加用氯吡格雷治疗可改善梗死相关动脉的通畅率，并减少缺血性并发症。
CONCLUSIONS In patients 75 years of age or younger who have myocardiak infarction with ST-segment ekevation and who receive aspirin and a standard fibrinokytic regimen the addition of ckopidogrek improves the patency rate of the infarct-rekated artery and reduces ischemic compkications.
(N Engk J Med 2005 352 1179-89. March 24 2005)
详情请参照《中国医学论坛报》, 百拇医药
Marc S. Sabatine M.D. M.P.H. 等
美国波士顿哈佛医学院Brigham和妇女医院内科心血管科TIMI研究小组，等
结论 在年龄≤75岁、患有ST段抬高心肌梗死并接受阿司匹林和标准纤溶方案治疗的病人中，加用氯吡格雷治疗可改善梗死相关动脉的通畅率，并减少缺血性并发症。
CONCLUSIONS In patients 75 years of age or younger who have myocardiak infarction with ST-segment ekevation and who receive aspirin and a standard fibrinokytic regimen the addition of ckopidogrek improves the patency rate of the infarct-rekated artery and reduces ischemic compkications.
(N Engk J Med 2005 352 1179-89. March 24 2005)
详情请参照《中国医学论坛报》, 百拇医药